A selective p38α/β MAPK inhibitor alleviates neuropathology and cognitive impairment, and modulates microglia function in 5XFAD mouse

Abstract Background Chronic neuroinflammation, aggressive amyloid beta (Aβ) deposition, neuronal cell loss, and cognitive impairment are pathological presentations of Alzheimer’s disease (AD). Therefore, resolution of neuroinflammation and inhibition of Aβ-driven pathology have been suggested to be...

Volledige beschrijving

Bibliografische gegevens

Hoofdauteurs:	Min Sung Gee, Seung Hwan Son, Seung Ho Jeon, Jimin Do, Namkwon Kim, Yeon-Joo Ju, Soo Jin Lee, Eun Kyoung Chung, Kyung-Soo Inn, Nam-Jung Kim, Jong Kil Lee
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	BMC 2020-04-01
Reeks:	Alzheimer’s Research & Therapy
Onderwerpen:	Alzheimer’s disease Amyloid-β P38 mitogen-activated protein kinase Kinase inhibitor Microglia
Online toegang:	http://link.springer.com/article/10.1186/s13195-020-00617-2
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!